Tirzepatide

Tirzepatide – Dual Incretin Receptor Agonist Peptide

Tirzepatide is a laboratory-grade research peptide designed to activate two key incretin receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Its dual agonist functionality makes it a relevant reagent for investigating mechanisms of glucose regulation, metabolic homeostasis, and appetite signalling in controlled in-vitro studies.

This lyophilized peptide is produced under stringent quality conditions and verified through HPLC analysis to ensure a purity level of ≥99%. It is supplied as a reagent for endocrinological and metabolic research models.

Key Specifications

• Name: Tirzepatide
• Synonym: LY3298176
• Form: Lyophilized Powder
• Purity: ≥99% (HPLC verified)
• Storage: Store refrigerated; protect from light and moisture
• Shelf life: Sealed lyophilizate. Shelf life 24 months from manufacture.

Research Applications

• Dual receptor activity supports advanced in-vitro study of glucose regulation and energy expenditure pathways.
• Studied in research models examining appetite signalling, lipid oxidation, and insulin secretion mechanisms.
• Used as a reference compound in incretin-based receptor binding and assay development.

A batch-specific Certificate of Analysis (CoA) is available on request and accompanies every order.